At present GLP-1 mimics, including semaglutide, are available for some groups on the NHS, although prescriptions can only be given for a maximum of two years because of a lack of long-term data
Drink water throughout the day and try electrolyte-rich drinks
How much weight can I lose on retatrutide?: Clinical Trials & Weight Loss Results The weight loss results from retatrutide clinical trials have been impressive, though its important to remember these are still early-stage studies with relatively small groups of participants
It is administered daily via an injection pen into the belly, thigh, or upper arm
Reddys says API issue delays commercial supplies of its generic semaglutide Dr

Phase 2 Trial Design Participants: 338 adults with obesity (BMI 30) or overweight with comorbidities (BMI 27), without diabetes Duration: 48 weeks Dosing groups: Placebo, 1mg, 4mg, 8mg, or 12mg weekly (with gradual dose escalation over 20-24 weeks) Primary endpoint: Percentage change in body weight from baseline Beyond Weight Loss: Metabolic Improvements Beyond weight loss, the 12mg dose also improved several cardiometabolic markers: Blood pressure: Systolic BP decreased by 7.4 mmHg (clinically significant reduction) Lipids: Triglycerides fell 30%, HDL cholesterol increased 8% Glucose control: HbA1c decreased 0.4% even in participants without diabetes Liver health: Markers of fatty liver disease (ALT, AST) improved significantly Inflammation: C-reactive protein (CRP) decreased, indicating reduced systemic inflammation What this means: Retatrutide appears to improve the metabolic dysfunction behind obesity-related diseases, not just the weight itself